Selected research
Market Analysis & Forecast
Global Injectable Drug Packaging Market Analysis and Forecast 2026-2032
Market perspective
The global Injectable Drug Packaging market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Injectable Drug Packaging is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Injectable Drug Packaging is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Injectable Drug Packaging is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Injectable Drug Packaging is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Injectable Drug Packaging include Becton,Dickinson and Company (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceuticals Industries Ltd. (Israel), Eli Lilly and Company (U.S.), Baxter International, Inc. (U.S.), Schott AG (Germany), Gerresheimer (Germany), Ypsomed (Switzerland) and B. Braun Melsungen (Germany), etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Injectable Drug Packaging, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Injectable Drug Packaging, also provides the sales of main regions and countries. Of the upcoming market potential for Injectable Drug Packaging, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Injectable Drug Packaging sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Injectable Drug Packaging market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Injectable Drug Packaging sales, projected growth trends, production technology, application and end-user industry.
Injectable Drug Packaging Segment by Company
Becton,Dickinson and Company (U.S.)
Pfizer Inc. (U.S.)
Teva Pharmaceuticals Industries Ltd. (Israel)
Eli Lilly and Company (U.S.)
Baxter International, Inc. (U.S.)
Schott AG (Germany)
Gerresheimer (Germany)
Ypsomed (Switzerland)
B. Braun Melsungen (Germany)
Injectable Drug Packaging Segment by Type
Ampules
Vials
Cartridges
Bottles
Injectable Drug Packaging Segment by Application
Hospitals & Clinics
Home Care Settings
Other Facilities of Use
Injectable Drug Packaging Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injectable Drug Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Injectable Drug Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injectable Drug Packaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Injectable Drug Packaging in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Injectable Drug Packaging manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Injectable Drug Packaging sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Ampules
- Vials
- Cartridges
- Bottles
Applications
- Hospitals & Clinics
- Home Care Settings
- Other Facilities of Use
Companies covered
- Becton,Dickinson and Company (U.S.)
- Pfizer Inc. (U.S.)
- Teva Pharmaceuticals Industries Ltd. (Israel)
- Eli Lilly and Company (U.S.)
- Baxter International, Inc. (U.S.)
- Schott AG (Germany)
- Gerresheimer (Germany)
- Ypsomed (Switzerland)
- B. Braun Melsungen (Germany)
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Injectable Drug Packaging Market by Type
- 1.2.1 Global Injectable Drug Packaging Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Ampules
- 1.2.3 Vials
- 1.2.4 Cartridges
- 1.2.5 Bottles
- 1.3 Injectable Drug Packaging Market by Application
- 1.3.1 Global Injectable Drug Packaging Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospitals & Clinics
- 1.3.3 Home Care Settings
- 1.3.4 Other Facilities of Use
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Injectable Drug Packaging Market Dynamics
- 2.1 Injectable Drug Packaging Industry Trends
- 2.2 Injectable Drug Packaging Industry Drivers
- 2.3 Injectable Drug Packaging Industry Opportunities and Challenges
- 2.4 Injectable Drug Packaging Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Injectable Drug Packaging Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Injectable Drug Packaging Revenue by Region
- 3.2.1 Global Injectable Drug Packaging Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Injectable Drug Packaging Revenue by Region (2021-2026)
- 3.2.3 Global Injectable Drug Packaging Revenue by Region (2027-2032)
- 3.2.4 Global Injectable Drug Packaging Revenue Market Share by Region (2021-2032)
- 3.3 Global Injectable Drug Packaging Sales Estimates and Forecasts 2021-2032
- 3.4 Global Injectable Drug Packaging Sales by Region
- 3.4.1 Global Injectable Drug Packaging Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Injectable Drug Packaging Sales by Region (2021-2026)
- 3.4.3 Global Injectable Drug Packaging Sales by Region (2027-2032)
- 3.4.4 Global Injectable Drug Packaging Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Injectable Drug Packaging Revenue by Manufacturers
- 4.1.1 Global Injectable Drug Packaging Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Injectable Drug Packaging Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Injectable Drug Packaging Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Injectable Drug Packaging Sales by Manufacturers
- 4.2.1 Global Injectable Drug Packaging Sales by Manufacturers (2021-2026)
- 4.2.2 Global Injectable Drug Packaging Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Injectable Drug Packaging Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Injectable Drug Packaging Sales Price by Manufacturers (2021-2026)
- 4.4 Global Injectable Drug Packaging Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Injectable Drug Packaging Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Injectable Drug Packaging Manufacturers, Product Type & Application
- 4.7 Global Injectable Drug Packaging Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Injectable Drug Packaging Market CR5 and HHI
- 4.8.2 2025 Injectable Drug Packaging Tier 1, Tier 2, and Tier 3
5 Injectable Drug Packaging Market by Type
- 5.1 Global Injectable Drug Packaging Revenue by Type
- 5.1.1 Global Injectable Drug Packaging Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Injectable Drug Packaging Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Injectable Drug Packaging Revenue Market Share by Type (2021-2032)
- 5.2 Global Injectable Drug Packaging Sales by Type
- 5.2.1 Global Injectable Drug Packaging Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Injectable Drug Packaging Sales by Type (2021-2032) & (k units)
- 5.2.3 Global Injectable Drug Packaging Sales Market Share by Type (2021-2032)
- 5.3 Global Injectable Drug Packaging Price by Type
6 Injectable Drug Packaging Market by Application
- 6.1 Global Injectable Drug Packaging Revenue by Application
- 6.1.1 Global Injectable Drug Packaging Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Injectable Drug Packaging Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Injectable Drug Packaging Revenue Market Share by Application (2021-2032)
- 6.2 Global Injectable Drug Packaging Sales by Application
- 6.2.1 Global Injectable Drug Packaging Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Injectable Drug Packaging Sales by Application (2021-2032) & (k units)
- 6.2.3 Global Injectable Drug Packaging Sales Market Share by Application (2021-2032)
- 6.3 Global Injectable Drug Packaging Price by Application
7 Company Profiles
- 7.1 Becton,Dickinson and Company (U.S.)
- 7.1.1 Becton,Dickinson and Company (U.S.) Company Information
- 7.1.2 Becton,Dickinson and Company (U.S.) Business Overview
- 7.1.3 Becton,Dickinson and Company (U.S.) Injectable Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Becton,Dickinson and Company (U.S.) Injectable Drug Packaging Product Portfolio
- 7.1.5 Becton,Dickinson and Company (U.S.) Recent Developments
- 7.2 Pfizer Inc. (U.S.)
- 7.2.1 Pfizer Inc. (U.S.) Company Information
- 7.2.2 Pfizer Inc. (U.S.) Business Overview
- 7.2.3 Pfizer Inc. (U.S.) Injectable Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Pfizer Inc. (U.S.) Injectable Drug Packaging Product Portfolio
- 7.2.5 Pfizer Inc. (U.S.) Recent Developments
- 7.3 Teva Pharmaceuticals Industries Ltd. (Israel)
- 7.3.1 Teva Pharmaceuticals Industries Ltd. (Israel) Company Information
- 7.3.2 Teva Pharmaceuticals Industries Ltd. (Israel) Business Overview
- 7.3.3 Teva Pharmaceuticals Industries Ltd. (Israel) Injectable Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Teva Pharmaceuticals Industries Ltd. (Israel) Injectable Drug Packaging Product Portfolio
- 7.3.5 Teva Pharmaceuticals Industries Ltd. (Israel) Recent Developments
- 7.4 Eli Lilly and Company (U.S.)
- 7.4.1 Eli Lilly and Company (U.S.) Company Information
- 7.4.2 Eli Lilly and Company (U.S.) Business Overview
- 7.4.3 Eli Lilly and Company (U.S.) Injectable Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Eli Lilly and Company (U.S.) Injectable Drug Packaging Product Portfolio
- 7.4.5 Eli Lilly and Company (U.S.) Recent Developments
- 7.5 Baxter International, Inc. (U.S.)
- 7.5.1 Baxter International, Inc. (U.S.) Company Information
- 7.5.2 Baxter International, Inc. (U.S.) Business Overview
- 7.5.3 Baxter International, Inc. (U.S.) Injectable Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Baxter International, Inc. (U.S.) Injectable Drug Packaging Product Portfolio
- 7.5.5 Baxter International, Inc. (U.S.) Recent Developments
- 7.6 Schott AG (Germany)
- 7.6.1 Schott AG (Germany) Company Information
- 7.6.2 Schott AG (Germany) Business Overview
- 7.6.3 Schott AG (Germany) Injectable Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Schott AG (Germany) Injectable Drug Packaging Product Portfolio
- 7.6.5 Schott AG (Germany) Recent Developments
- 7.7 Gerresheimer (Germany)
- 7.7.1 Gerresheimer (Germany) Company Information
- 7.7.2 Gerresheimer (Germany) Business Overview
- 7.7.3 Gerresheimer (Germany) Injectable Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Gerresheimer (Germany) Injectable Drug Packaging Product Portfolio
- 7.7.5 Gerresheimer (Germany) Recent Developments
- 7.8 Ypsomed (Switzerland)
- 7.8.1 Ypsomed (Switzerland) Company Information
- 7.8.2 Ypsomed (Switzerland) Business Overview
- 7.8.3 Ypsomed (Switzerland) Injectable Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Ypsomed (Switzerland) Injectable Drug Packaging Product Portfolio
- 7.8.5 Ypsomed (Switzerland) Recent Developments
- 7.9 B. Braun Melsungen (Germany)
- 7.9.1 B. Braun Melsungen (Germany) Company Information
- 7.9.2 B. Braun Melsungen (Germany) Business Overview
- 7.9.3 B. Braun Melsungen (Germany) Injectable Drug Packaging Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 B. Braun Melsungen (Germany) Injectable Drug Packaging Product Portfolio
- 7.9.5 B. Braun Melsungen (Germany) Recent Developments
8 North America
- 8.1 North America Injectable Drug Packaging Market Size by Type
- 8.1.1 North America Injectable Drug Packaging Revenue by Type (2021-2032)
- 8.1.2 North America Injectable Drug Packaging Sales by Type (2021-2032)
- 8.1.3 North America Injectable Drug Packaging Price by Type (2021-2032)
- 8.2 North America Injectable Drug Packaging Market Size by Application
- 8.2.1 North America Injectable Drug Packaging Revenue by Application (2021-2032)
- 8.2.2 North America Injectable Drug Packaging Sales by Application (2021-2032)
- 8.2.3 North America Injectable Drug Packaging Price by Application (2021-2032)
- 8.3 North America Injectable Drug Packaging Market Size by Country
- 8.3.1 North America Injectable Drug Packaging Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Injectable Drug Packaging Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Injectable Drug Packaging Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Injectable Drug Packaging Market Size by Type
- 9.1.1 Europe Injectable Drug Packaging Revenue by Type (2021-2032)
- 9.1.2 Europe Injectable Drug Packaging Sales by Type (2021-2032)
- 9.1.3 Europe Injectable Drug Packaging Price by Type (2021-2032)
- 9.2 Europe Injectable Drug Packaging Market Size by Application
- 9.2.1 Europe Injectable Drug Packaging Revenue by Application (2021-2032)
- 9.2.2 Europe Injectable Drug Packaging Sales by Application (2021-2032)
- 9.2.3 Europe Injectable Drug Packaging Price by Application (2021-2032)
- 9.3 Europe Injectable Drug Packaging Market Size by Country
- 9.3.1 Europe Injectable Drug Packaging Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Injectable Drug Packaging Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Injectable Drug Packaging Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Injectable Drug Packaging Market Size by Type
- 10.1.1 China Injectable Drug Packaging Revenue by Type (2021-2032)
- 10.1.2 China Injectable Drug Packaging Sales by Type (2021-2032)
- 10.1.3 China Injectable Drug Packaging Price by Type (2021-2032)
- 10.2 China Injectable Drug Packaging Market Size by Application
- 10.2.1 China Injectable Drug Packaging Revenue by Application (2021-2032)
- 10.2.2 China Injectable Drug Packaging Sales by Application (2021-2032)
- 10.2.3 China Injectable Drug Packaging Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Injectable Drug Packaging Market Size by Type
- 11.1.1 Asia Injectable Drug Packaging Revenue by Type (2021-2032)
- 11.1.2 Asia Injectable Drug Packaging Sales by Type (2021-2032)
- 11.1.3 Asia Injectable Drug Packaging Price by Type (2021-2032)
- 11.2 Asia Injectable Drug Packaging Market Size by Application
- 11.2.1 Asia Injectable Drug Packaging Revenue by Application (2021-2032)
- 11.2.2 Asia Injectable Drug Packaging Sales by Application (2021-2032)
- 11.2.3 Asia Injectable Drug Packaging Price by Application (2021-2032)
- 11.3 Asia Injectable Drug Packaging Market Size by Country
- 11.3.1 Asia Injectable Drug Packaging Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Injectable Drug Packaging Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Injectable Drug Packaging Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Injectable Drug Packaging Market Size by Type
- 12.1.1 SAMEA Injectable Drug Packaging Revenue by Type (2021-2032)
- 12.1.2 SAMEA Injectable Drug Packaging Sales by Type (2021-2032)
- 12.1.3 SAMEA Injectable Drug Packaging Price by Type (2021-2032)
- 12.2 SAMEA Injectable Drug Packaging Market Size by Application
- 12.2.1 SAMEA Injectable Drug Packaging Revenue by Application (2021-2032)
- 12.2.2 SAMEA Injectable Drug Packaging Sales by Application (2021-2032)
- 12.2.3 SAMEA Injectable Drug Packaging Price by Application (2021-2032)
- 12.3 SAMEA Injectable Drug Packaging Market Size by Country
- 12.3.1 SAMEA Injectable Drug Packaging Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Injectable Drug Packaging Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Injectable Drug Packaging Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Injectable Drug Packaging Value Chain Analysis
- 13.1.1 Injectable Drug Packaging Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Injectable Drug Packaging Production Mode & Process
- 13.2 Injectable Drug Packaging Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Injectable Drug Packaging Distributors
- 13.2.3 Injectable Drug Packaging Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst